Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Turkish Coffee Consumption Elevates Cardiovascular Risk Markers, Decreases Leptin Hormone Levels, and Impairs Sleep Quality in Healthy Young Women: A Pilot Randomized Controlled Trial

NCT07133373 is registered in ClinicalTrials.gov with University of Petra as lead sponsor.

NCT NCT07133373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07133373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Turkish Coffee Consumption Elevates Cardiovascular Risk Markers, Decreases Leptin Hormone Levels, and Impairs Sleep Quality in Healthy Young Women: A Pilot Randomized Controlled Trial
Lead sponsor
University of Petra
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2024
Completion date
October 30, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic health markers, appetite-regulating hormones, inflammation, and sleep quality in healthy women, effects of turkish coffee consumption on cardiovascular markers and sleep in healthy women